ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 92 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,315,233 | -18.1% | 48,948 | +8.6% | 0.00% | 0.0% |
Q2 2023 | $1,606,768 | +27.0% | 45,058 | -9.5% | 0.00% | +100.0% |
Q1 2023 | $1,265,301 | -48.7% | 49,815 | -18.1% | 0.00% | -66.7% |
Q4 2022 | $2,467,468 | +18.5% | 60,835 | -3.5% | 0.00% | +50.0% |
Q3 2022 | $2,083,000 | +19.1% | 63,019 | +26.9% | 0.00% | 0.0% |
Q2 2022 | $1,749,000 | -8.0% | 49,669 | +7.4% | 0.00% | 0.0% |
Q1 2022 | $1,901,000 | -21.7% | 46,247 | +26.2% | 0.00% | 0.0% |
Q4 2021 | $2,429,000 | -2.7% | 36,637 | -8.4% | 0.00% | 0.0% |
Q3 2021 | $2,497,000 | -30.4% | 39,998 | -7.7% | 0.00% | -33.3% |
Q2 2021 | $3,590,000 | +11.9% | 43,343 | -10.4% | 0.00% | 0.0% |
Q1 2021 | $3,207,000 | -18.5% | 48,359 | -5.7% | 0.00% | -25.0% |
Q4 2020 | $3,936,000 | +70.0% | 51,301 | -4.6% | 0.00% | +33.3% |
Q3 2020 | $2,315,000 | -20.4% | 53,760 | -20.1% | 0.00% | -25.0% |
Q2 2020 | $2,908,000 | -23.4% | 67,323 | -49.0% | 0.00% | +33.3% |
Q1 2020 | $3,798,000 | -10.4% | 131,986 | +97.4% | 0.00% | -40.0% |
Q4 2019 | $4,241,000 | +47.4% | 66,863 | -34.5% | 0.01% | +25.0% |
Q3 2019 | $2,878,000 | +4195.5% | 102,138 | +3964.4% | 0.00% | – |
Q2 2019 | $67,000 | +45.7% | 2,513 | 0.0% | 0.00% | – |
Q1 2019 | $46,000 | +48.4% | 2,513 | 0.0% | 0.00% | – |
Q4 2018 | $31,000 | -45.6% | 2,513 | -16.0% | 0.00% | – |
Q3 2018 | $57,000 | +62.9% | 2,992 | +15.1% | 0.00% | – |
Q2 2018 | $35,000 | +34.6% | 2,599 | -27.8% | 0.00% | – |
Q1 2018 | $26,000 | +100.0% | 3,599 | 0.0% | 0.00% | – |
Q4 2017 | $13,000 | -18.8% | 3,599 | 0.0% | 0.00% | – |
Q3 2017 | $16,000 | +166.7% | 3,599 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | -14.3% | 3,599 | +1.8% | 0.00% | – |
Q1 2017 | $7,000 | +40.0% | 3,537 | 0.0% | 0.00% | – |
Q4 2016 | $5,000 | -80.0% | 3,537 | +5.9% | 0.00% | – |
Q3 2016 | $25,000 | – | 3,340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $20,836,128 | 14.83% |
Aquilo Capital Management, LLC | 1,018,474 | $25,869,240 | 10.72% |
Rokos Capital Management LLP | 1,675,921 | $41,537,702 | 3.07% |
COMMODORE CAPITAL LP | 575,000 | $14,605,000 | 2.22% |
Privium Fund Management B.V. | 259,036 | $6,579,514 | 2.21% |
JOHNSON & JOHNSON | 247,598 | $6,288,989 | 2.05% |
WEALTH EFFECTS LLC | 156,810 | $3,982,976 | 2.04% |
M28 Capital Management LP | 67,400 | $1,711,960 | 1.94% |
Evolutionary Tree Capital Management, LLC | 51,878 | $1,317,701 | 1.83% |
Avidity Partners Management LP | 1,741,300 | $44,229,020 | 1.47% |